nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—ABCB1—peripheral nervous system neoplasm	0.384	1	CbGaD
Spironolactone—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0571	0.129	CbGbCtD
Spironolactone—ABCC2—Vincristine—peripheral nervous system neoplasm	0.0544	0.123	CbGbCtD
Spironolactone—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.0507	0.114	CbGbCtD
Spironolactone—ABCC2—Etoposide—peripheral nervous system neoplasm	0.0499	0.112	CbGbCtD
Spironolactone—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0416	0.0937	CbGbCtD
Spironolactone—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0416	0.0937	CbGbCtD
Spironolactone—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.034	0.0767	CbGbCtD
Spironolactone—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0288	0.0649	CbGbCtD
Spironolactone—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.024	0.0541	CbGbCtD
Spironolactone—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0177	0.04	CbGbCtD
Spironolactone—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0165	0.0373	CbGbCtD
Spironolactone—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0163	0.0366	CbGbCtD
Spironolactone—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0111	0.025	CbGbCtD
Spironolactone—CYP11B2—Metabolism of steroid hormones and vitamin D—HSD17B12—peripheral nervous system neoplasm	0.0025	0.0941	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of steroid hormones and vitamin D—HSD17B12—peripheral nervous system neoplasm	0.00215	0.0811	CbGpPWpGaD
Spironolactone—NR3C2—ACE Inhibitor Pathway—KNG1—peripheral nervous system neoplasm	0.00169	0.0636	CbGpPWpGaD
Spironolactone—CYP11B2—ACE Inhibitor Pathway—KNG1—peripheral nervous system neoplasm	0.00138	0.052	CbGpPWpGaD
Spironolactone—ABCC2—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.00107	0.0401	CbGpPWpGaD
Spironolactone—Drospirenone—BCHE—peripheral nervous system neoplasm	0.000959	0.519	CrCbGaD
Spironolactone—ABCC2—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000904	0.034	CbGpPWpGaD
Spironolactone—Stevens-Johnson syndrome—Alitretinoin—peripheral nervous system neoplasm	0.000632	0.00437	CcSEcCtD
Spironolactone—Renal failure—Alitretinoin—peripheral nervous system neoplasm	0.000626	0.00434	CcSEcCtD
Spironolactone—Ill-defined disorder—Topotecan—peripheral nervous system neoplasm	0.000614	0.00425	CcSEcCtD
Spironolactone—Ill-defined disorder—Tretinoin—peripheral nervous system neoplasm	0.000609	0.00422	CcSEcCtD
Spironolactone—Ill-defined disorder—Isotretinoin—peripheral nervous system neoplasm	0.000609	0.00422	CcSEcCtD
Spironolactone—Rash erythematous—Doxorubicin—peripheral nervous system neoplasm	0.000602	0.00417	CcSEcCtD
Spironolactone—Malaise—Topotecan—peripheral nervous system neoplasm	0.000597	0.00413	CcSEcCtD
Spironolactone—Agranulocytosis—Alitretinoin—peripheral nervous system neoplasm	0.000594	0.00412	CcSEcCtD
Spironolactone—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.000593	0.0041	CcSEcCtD
Spironolactone—Malaise—Tretinoin—peripheral nervous system neoplasm	0.000592	0.0041	CcSEcCtD
Spironolactone—Malaise—Isotretinoin—peripheral nervous system neoplasm	0.000592	0.0041	CcSEcCtD
Spironolactone—Erythema multiforme—Dactinomycin—peripheral nervous system neoplasm	0.000583	0.00404	CcSEcCtD
Spironolactone—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000583	0.0219	CbGpPWpGaD
Spironolactone—Cramp muscle—Etoposide—peripheral nervous system neoplasm	0.000581	0.00402	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Etoposide—peripheral nervous system neoplasm	0.000581	0.00402	CcSEcCtD
Spironolactone—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.00058	0.00402	CcSEcCtD
Spironolactone—Breast pain—Epirubicin—peripheral nervous system neoplasm	0.000571	0.00395	CcSEcCtD
Spironolactone—Amenorrhoea—Epirubicin—peripheral nervous system neoplasm	0.000567	0.00393	CcSEcCtD
Spironolactone—Discomfort—Topotecan—peripheral nervous system neoplasm	0.000557	0.00386	CcSEcCtD
Spironolactone—Discomfort—Tretinoin—peripheral nervous system neoplasm	0.000553	0.00383	CcSEcCtD
Spironolactone—Discomfort—Isotretinoin—peripheral nervous system neoplasm	0.000553	0.00383	CcSEcCtD
Spironolactone—Alopecia—Dactinomycin—peripheral nervous system neoplasm	0.000545	0.00377	CcSEcCtD
Spironolactone—Erythema multiforme—Alitretinoin—peripheral nervous system neoplasm	0.000541	0.00374	CcSEcCtD
Spironolactone—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.000541	0.00374	CcSEcCtD
Spironolactone—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.000541	0.00374	CcSEcCtD
Spironolactone—AR—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00054	0.0203	CbGpPWpGaD
Spironolactone—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00054	0.00374	CcSEcCtD
Spironolactone—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.000536	0.00371	CcSEcCtD
Spironolactone—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.000536	0.00371	CcSEcCtD
Spironolactone—Renal failure—Cisplatin—peripheral nervous system neoplasm	0.000534	0.00369	CcSEcCtD
Spironolactone—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.000529	0.00366	CcSEcCtD
Spironolactone—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.000529	0.00366	CcSEcCtD
Spironolactone—Breast pain—Doxorubicin—peripheral nervous system neoplasm	0.000528	0.00366	CcSEcCtD
Spironolactone—Ulcer—Epirubicin—peripheral nervous system neoplasm	0.000527	0.00365	CcSEcCtD
Spironolactone—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.000525	0.00363	CcSEcCtD
Spironolactone—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.000525	0.00363	CcSEcCtD
Spironolactone—Amenorrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000525	0.00363	CcSEcCtD
Spironolactone—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.000518	0.00359	CcSEcCtD
Spironolactone—Alopecia—Alitretinoin—peripheral nervous system neoplasm	0.000505	0.0035	CcSEcCtD
Spironolactone—Ill-defined disorder—Dactinomycin—peripheral nervous system neoplasm	0.000498	0.00345	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Etoposide—peripheral nervous system neoplasm	0.000493	0.00341	CcSEcCtD
Spironolactone—Hyperkalaemia—Epirubicin—peripheral nervous system neoplasm	0.00049	0.00339	CcSEcCtD
Spironolactone—Renal failure—Etoposide—peripheral nervous system neoplasm	0.000489	0.00338	CcSEcCtD
Spironolactone—Ulcer—Doxorubicin—peripheral nervous system neoplasm	0.000487	0.00337	CcSEcCtD
Spironolactone—Alopecia—Vincristine—peripheral nervous system neoplasm	0.000487	0.00337	CcSEcCtD
Spironolactone—Malaise—Dactinomycin—peripheral nervous system neoplasm	0.000484	0.00335	CcSEcCtD
Spironolactone—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.000481	0.00333	CcSEcCtD
Spironolactone—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.000477	0.0033	CcSEcCtD
Spironolactone—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.000477	0.0033	CcSEcCtD
Spironolactone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—peripheral nervous system neoplasm	0.000476	0.0179	CbGpPWpGaD
Spironolactone—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000467	0.00323	CcSEcCtD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—COX2—peripheral nervous system neoplasm	0.000466	0.0175	CbGpPWpGaD
Spironolactone—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.000464	0.00321	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000463	0.0032	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000463	0.0032	CcSEcCtD
Spironolactone—Ill-defined disorder—Alitretinoin—peripheral nervous system neoplasm	0.000462	0.0032	CcSEcCtD
Spironolactone—Cramps of lower extremities—Epirubicin—peripheral nervous system neoplasm	0.000458	0.00317	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000457	0.00316	CcSEcCtD
Spironolactone—Hyperkalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000453	0.00314	CcSEcCtD
Spironolactone—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000452	0.00313	CcSEcCtD
Spironolactone—NR3C1—FOXA2 and FOXA3 transcription factor networks—NF1—peripheral nervous system neoplasm	0.000449	0.0169	CbGpPWpGaD
Spironolactone—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.000449	0.00311	CcSEcCtD
Spironolactone—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000445	0.00308	CcSEcCtD
Spironolactone—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000442	0.00306	CcSEcCtD
Spironolactone—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000442	0.00306	CcSEcCtD
Spironolactone—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.000431	0.00298	CcSEcCtD
Spironolactone—Megestrol acetate—ABCB1—peripheral nervous system neoplasm	0.00043	0.233	CrCbGaD
Spironolactone—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.000429	0.00297	CcSEcCtD
Spironolactone—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000429	0.00297	CcSEcCtD
Spironolactone—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000429	0.00297	CcSEcCtD
Spironolactone—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000427	0.00296	CcSEcCtD
Spironolactone—NR3C1—AP-1 transcription factor network—NTS—peripheral nervous system neoplasm	0.000427	0.0161	CbGpPWpGaD
Spironolactone—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000426	0.00295	CcSEcCtD
Spironolactone—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000426	0.00295	CcSEcCtD
Spironolactone—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000424	0.00293	CcSEcCtD
Spironolactone—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000424	0.00293	CcSEcCtD
Spironolactone—Cramps of lower extremities—Doxorubicin—peripheral nervous system neoplasm	0.000424	0.00293	CcSEcCtD
Spironolactone—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.000422	0.00292	CcSEcCtD
Spironolactone—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00042	0.00291	CcSEcCtD
Spironolactone—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000419	0.0029	CcSEcCtD
Spironolactone—SHBG—Nongenotropic Androgen signaling—HRAS—peripheral nervous system neoplasm	0.000418	0.0157	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00041	0.0154	CbGpPWpGaD
Spironolactone—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00041	0.00284	CcSEcCtD
Spironolactone—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000408	0.00282	CcSEcCtD
Spironolactone—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000406	0.00281	CcSEcCtD
Spironolactone—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000398	0.00276	CcSEcCtD
Spironolactone—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000398	0.00275	CcSEcCtD
Spironolactone—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000395	0.00273	CcSEcCtD
Spironolactone—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000395	0.00273	CcSEcCtD
Spironolactone—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000394	0.00273	CcSEcCtD
Spironolactone—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.000394	0.00272	CcSEcCtD
Spironolactone—Renal failure acute—Epirubicin—peripheral nervous system neoplasm	0.000392	0.00271	CcSEcCtD
Spironolactone—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000391	0.00271	CcSEcCtD
Spironolactone—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00039	0.0027	CcSEcCtD
Spironolactone—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000383	0.00265	CcSEcCtD
Spironolactone—Malaise—Cisplatin—peripheral nervous system neoplasm	0.000383	0.00265	CcSEcCtD
Spironolactone—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000382	0.00265	CcSEcCtD
Spironolactone—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00038	0.00263	CcSEcCtD
Spironolactone—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000379	0.00263	CcSEcCtD
Spironolactone—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000379	0.00263	CcSEcCtD
Spironolactone—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000374	0.00259	CcSEcCtD
Spironolactone—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000374	0.00259	CcSEcCtD
Spironolactone—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00037	0.00256	CcSEcCtD
Spironolactone—SHBG—Nongenotropic Androgen signaling—AKT1—peripheral nervous system neoplasm	0.00037	0.0139	CbGpPWpGaD
Spironolactone—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000369	0.00256	CcSEcCtD
Spironolactone—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000367	0.00254	CcSEcCtD
Spironolactone—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000367	0.00254	CcSEcCtD
Spironolactone—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	0.000362	0.00251	CcSEcCtD
Spironolactone—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000362	0.00251	CcSEcCtD
Spironolactone—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000361	0.0025	CcSEcCtD
Spironolactone—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000361	0.0025	CcSEcCtD
Spironolactone—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000361	0.0025	CcSEcCtD
Spironolactone—AR—Integrated Breast Cancer Pathway—BARD1—peripheral nervous system neoplasm	0.000357	0.0135	CbGpPWpGaD
Spironolactone—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000357	0.00247	CcSEcCtD
Spironolactone—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000357	0.00247	CcSEcCtD
Spironolactone—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000355	0.00245	CcSEcCtD
Spironolactone—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000355	0.00245	CcSEcCtD
Spironolactone—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000351	0.0132	CbGpPWpGaD
Spironolactone—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000351	0.00243	CcSEcCtD
Spironolactone—Malaise—Etoposide—peripheral nervous system neoplasm	0.00035	0.00243	CcSEcCtD
Spironolactone—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000348	0.00241	CcSEcCtD
Spironolactone—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000346	0.0024	CcSEcCtD
Spironolactone—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000346	0.0024	CcSEcCtD
Spironolactone—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000344	0.00238	CcSEcCtD
Spironolactone—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.00236	CcSEcCtD
Spironolactone—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000341	0.00236	CcSEcCtD
Spironolactone—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000341	0.00236	CcSEcCtD
Spironolactone—Rash—Topotecan—peripheral nervous system neoplasm	0.000341	0.00236	CcSEcCtD
Spironolactone—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00034	0.00236	CcSEcCtD
Spironolactone—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.00034	0.00235	CcSEcCtD
Spironolactone—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000339	0.00235	CcSEcCtD
Spironolactone—Headache—Topotecan—peripheral nervous system neoplasm	0.000339	0.00234	CcSEcCtD
Spironolactone—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000338	0.00234	CcSEcCtD
Spironolactone—Rash—Tretinoin—peripheral nervous system neoplasm	0.000338	0.00234	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000338	0.00234	CcSEcCtD
Spironolactone—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000338	0.00234	CcSEcCtD
Spironolactone—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000338	0.00234	CcSEcCtD
Spironolactone—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000336	0.00233	CcSEcCtD
Spironolactone—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000336	0.00232	CcSEcCtD
Spironolactone—Headache—Tretinoin—peripheral nervous system neoplasm	0.000336	0.00232	CcSEcCtD
Spironolactone—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000335	0.0126	CbGpPWpGaD
Spironolactone—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000335	0.00232	CcSEcCtD
Spironolactone—Rash—Melphalan—peripheral nervous system neoplasm	0.000334	0.00231	CcSEcCtD
Spironolactone—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000333	0.00231	CcSEcCtD
Spironolactone—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000327	0.00226	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000326	0.00225	CcSEcCtD
Spironolactone—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000323	0.00223	CcSEcCtD
Spironolactone—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000323	0.00223	CcSEcCtD
Spironolactone—PGR—Nuclear signaling by ERBB4—PTPN11—peripheral nervous system neoplasm	0.000322	0.0121	CbGpPWpGaD
Spironolactone—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000321	0.00222	CcSEcCtD
Spironolactone—Nausea—Topotecan—peripheral nervous system neoplasm	0.000321	0.00222	CcSEcCtD
Spironolactone—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.00032	0.00222	CcSEcCtD
Spironolactone—ABCC2—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	0.00032	0.012	CbGpPWpGaD
Spironolactone—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00032	0.00221	CcSEcCtD
Spironolactone—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000318	0.0022	CcSEcCtD
Spironolactone—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000318	0.0022	CcSEcCtD
Spironolactone—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000317	0.0022	CcSEcCtD
Spironolactone—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.00218	CcSEcCtD
Spironolactone—Nausea—Melphalan—peripheral nervous system neoplasm	0.000314	0.00218	CcSEcCtD
Spironolactone—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000311	0.00215	CcSEcCtD
Spironolactone—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.00031	0.00214	CcSEcCtD
Spironolactone—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000309	0.00214	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.00209	CcSEcCtD
Spironolactone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.0003	0.00208	CcSEcCtD
Spironolactone—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000299	0.00207	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000299	0.00207	CcSEcCtD
Spironolactone—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.00205	CcSEcCtD
Spironolactone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000288	0.002	CcSEcCtD
Spironolactone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000287	0.00199	CcSEcCtD
Spironolactone—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.00198	CcSEcCtD
Spironolactone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000285	0.00197	CcSEcCtD
Spironolactone—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000282	0.00195	CcSEcCtD
Spironolactone—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000279	0.00193	CcSEcCtD
Spironolactone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000279	0.00193	CcSEcCtD
Spironolactone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000278	0.00192	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000276	0.00191	CcSEcCtD
Spironolactone—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000276	0.00191	CcSEcCtD
Spironolactone—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000274	0.0019	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000274	0.0019	CcSEcCtD
Spironolactone—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000274	0.00189	CcSEcCtD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—GNAS—peripheral nervous system neoplasm	0.00027	0.0101	CbGpPWpGaD
Spironolactone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000269	0.00186	CcSEcCtD
Spironolactone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000268	0.00185	CcSEcCtD
Spironolactone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000261	0.00181	CcSEcCtD
Spironolactone—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00026	0.0018	CcSEcCtD
Spironolactone—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00026	0.0018	CcSEcCtD
Spironolactone—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000259	0.00179	CcSEcCtD
Spironolactone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000258	0.00179	CcSEcCtD
Spironolactone—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.00179	CcSEcCtD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000256	0.00965	CbGpPWpGaD
Spironolactone—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000256	0.00177	CcSEcCtD
Spironolactone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000256	0.00177	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.00177	CcSEcCtD
Spironolactone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000255	0.00177	CcSEcCtD
Spironolactone—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000255	0.00176	CcSEcCtD
Spironolactone—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.00176	CcSEcCtD
Spironolactone—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000252	0.00174	CcSEcCtD
Spironolactone—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000251	0.00174	CcSEcCtD
Spironolactone—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000249	0.00172	CcSEcCtD
Spironolactone—Rash—Vincristine—peripheral nervous system neoplasm	0.000247	0.00171	CcSEcCtD
Spironolactone—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000247	0.00171	CcSEcCtD
Spironolactone—Headache—Vincristine—peripheral nervous system neoplasm	0.000245	0.0017	CcSEcCtD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—IFNB1—peripheral nervous system neoplasm	0.000243	0.00913	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000241	0.00909	CbGpPWpGaD
Spironolactone—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000241	0.00167	CcSEcCtD
Spironolactone—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.00167	CcSEcCtD
Spironolactone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000237	0.00164	CcSEcCtD
Spironolactone—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000237	0.00164	CcSEcCtD
Spironolactone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000234	0.00162	CcSEcCtD
Spironolactone—Nausea—Vincristine—peripheral nervous system neoplasm	0.000233	0.00161	CcSEcCtD
Spironolactone—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000224	0.00155	CcSEcCtD
Spironolactone—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000221	0.00153	CcSEcCtD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000221	0.00831	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	0.000221	0.00831	CbGpPWpGaD
Spironolactone—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00022	0.00152	CcSEcCtD
Spironolactone—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.00152	CcSEcCtD
Spironolactone—Rash—Cisplatin—peripheral nervous system neoplasm	0.000218	0.00151	CcSEcCtD
Spironolactone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000218	0.00151	CcSEcCtD
Spironolactone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000217	0.0015	CcSEcCtD
Spironolactone—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00021	0.00145	CcSEcCtD
Spironolactone—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000209	0.00145	CcSEcCtD
Spironolactone—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000206	0.00142	CcSEcCtD
Spironolactone—NR3C1—AP-1 transcription factor network—TH—peripheral nervous system neoplasm	0.000205	0.00773	CbGpPWpGaD
Spironolactone—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.00142	CcSEcCtD
Spironolactone—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000202	0.0014	CcSEcCtD
Spironolactone—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000202	0.0014	CcSEcCtD
Spironolactone—Rash—Etoposide—peripheral nervous system neoplasm	0.0002	0.00138	CcSEcCtD
Spironolactone—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.0002	0.00138	CcSEcCtD
Spironolactone—Headache—Etoposide—peripheral nervous system neoplasm	0.000199	0.00138	CcSEcCtD
Spironolactone—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000196	0.00136	CcSEcCtD
Spironolactone—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000195	0.00135	CcSEcCtD
Spironolactone—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.00134	CcSEcCtD
Spironolactone—Nausea—Etoposide—peripheral nervous system neoplasm	0.000188	0.0013	CcSEcCtD
Spironolactone—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.00129	CcSEcCtD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—peripheral nervous system neoplasm	0.000184	0.00692	CbGpPWpGaD
Spironolactone—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000183	0.00127	CcSEcCtD
Spironolactone—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.00126	CcSEcCtD
Spironolactone—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.00125	CcSEcCtD
Spironolactone—NR3C2—Gene Expression—EED—peripheral nervous system neoplasm	0.00018	0.00676	CbGpPWpGaD
Spironolactone—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000179	0.00124	CcSEcCtD
Spironolactone—Hydrocortisone—ABCB1—peripheral nervous system neoplasm	0.000178	0.0961	CrCbGaD
Spironolactone—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000178	0.00123	CcSEcCtD
Spironolactone—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000174	0.0012	CcSEcCtD
Spironolactone—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.00117	CcSEcCtD
Spironolactone—CYP11B2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000169	0.00636	CbGpPWpGaD
Spironolactone—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.00115	CcSEcCtD
Spironolactone—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.00114	CcSEcCtD
Spironolactone—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.00111	CcSEcCtD
Spironolactone—AR—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	0.00016	0.00601	CbGpPWpGaD
Spironolactone—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000158	0.00109	CcSEcCtD
Spironolactone—AR—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000156	0.00585	CbGpPWpGaD
Spironolactone—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000153	0.00106	CcSEcCtD
Spironolactone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000146	0.00101	CcSEcCtD
Spironolactone—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.00101	CcSEcCtD
Spironolactone—CYP11B1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000146	0.00548	CbGpPWpGaD
Spironolactone—Progesterone—ABCB1—peripheral nervous system neoplasm	0.000145	0.0783	CrCbGaD
Spironolactone—NR3C2—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.000144	0.0054	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000143	0.00537	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000143	0.00536	CbGpPWpGaD
Spironolactone—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000983	CcSEcCtD
Spironolactone—AR—Coregulation of Androgen receptor activity—CDKN2A—peripheral nervous system neoplasm	0.000142	0.00533	CbGpPWpGaD
Spironolactone—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000978	CcSEcCtD
Spironolactone—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000973	CcSEcCtD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000138	0.00521	CbGpPWpGaD
Spironolactone—Testosterone—ABCB1—peripheral nervous system neoplasm	0.000137	0.074	CrCbGaD
Spironolactone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000938	CcSEcCtD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—CASP3—peripheral nervous system neoplasm	0.000134	0.00506	CbGpPWpGaD
Spironolactone—ABCC2—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000132	0.00497	CbGpPWpGaD
Spironolactone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000907	CcSEcCtD
Spironolactone—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000905	CcSEcCtD
Spironolactone—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.0009	CcSEcCtD
Spironolactone—AR—Nongenotropic Androgen signaling—HRAS—peripheral nervous system neoplasm	0.00013	0.00488	CbGpPWpGaD
Spironolactone—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000871	CcSEcCtD
Spironolactone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000842	CcSEcCtD
Spironolactone—PGR—Validated nuclear estrogen receptor alpha network—MYC—peripheral nervous system neoplasm	0.000121	0.00456	CbGpPWpGaD
Spironolactone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000839	CcSEcCtD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000118	0.00445	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000118	0.00444	CbGpPWpGaD
Spironolactone—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000814	CcSEcCtD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000117	0.00441	CbGpPWpGaD
Spironolactone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000806	CcSEcCtD
Spironolactone—AR—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000116	0.00437	CbGpPWpGaD
Spironolactone—AR—Nongenotropic Androgen signaling—AKT1—peripheral nervous system neoplasm	0.000114	0.00431	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000114	0.0043	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—peripheral nervous system neoplasm	0.000114	0.00429	CbGpPWpGaD
Spironolactone—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000782	CcSEcCtD
Spironolactone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000779	CcSEcCtD
Spironolactone—Rash—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000776	CcSEcCtD
Spironolactone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000775	CcSEcCtD
Spironolactone—Headache—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000771	CcSEcCtD
Spironolactone—PGR—Gene Expression—EED—peripheral nervous system neoplasm	0.000109	0.00412	CbGpPWpGaD
Spironolactone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000753	CcSEcCtD
Spironolactone—PGR—Signaling by ERBB4—PTPN11—peripheral nervous system neoplasm	0.000108	0.00408	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000108	0.00407	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000108	0.00406	CbGpPWpGaD
Spironolactone—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000731	CcSEcCtD
Spironolactone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000724	CcSEcCtD
Spironolactone—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000718	CcSEcCtD
Spironolactone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000717	CcSEcCtD
Spironolactone—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000713	CcSEcCtD
Spironolactone—ABCC2—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000101	0.00381	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	9.88e-05	0.00372	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	9.84e-05	0.0037	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.84e-05	0.0037	CbGpPWpGaD
Spironolactone—Nausea—Doxorubicin—peripheral nervous system neoplasm	9.77e-05	0.000676	CcSEcCtD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	9.71e-05	0.00365	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	9.63e-05	0.00362	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	9.49e-05	0.00357	CbGpPWpGaD
Spironolactone—SLCO1A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	9.15e-05	0.00344	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.13e-05	0.00344	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	8.81e-05	0.00331	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	8.79e-05	0.00331	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—SUZ12—peripheral nervous system neoplasm	8.74e-05	0.00329	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—ERBB2—peripheral nervous system neoplasm	8.56e-05	0.00322	CbGpPWpGaD
Spironolactone—AR—Gene Expression—EED—peripheral nervous system neoplasm	8.33e-05	0.00314	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—GNS—peripheral nervous system neoplasm	8.25e-05	0.00311	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	8.18e-05	0.00308	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	8e-05	0.00301	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—NME1—peripheral nervous system neoplasm	7.91e-05	0.00298	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—peripheral nervous system neoplasm	7.73e-05	0.00291	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—peripheral nervous system neoplasm	7.65e-05	0.00288	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—COX2—peripheral nervous system neoplasm	7.62e-05	0.00287	CbGpPWpGaD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—AKT1—peripheral nervous system neoplasm	7.28e-05	0.00274	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GNS—peripheral nervous system neoplasm	7.11e-05	0.00268	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—NME1—peripheral nervous system neoplasm	6.82e-05	0.00257	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	6.81e-05	0.00256	CbGpPWpGaD
Spironolactone—AR—Gene Expression—SUZ12—peripheral nervous system neoplasm	6.66e-05	0.00251	CbGpPWpGaD
Spironolactone—AR—Coregulation of Androgen receptor activity—AKT1—peripheral nervous system neoplasm	6.66e-05	0.0025	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—COX2—peripheral nervous system neoplasm	6.56e-05	0.00247	CbGpPWpGaD
Spironolactone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	6.56e-05	0.00247	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—MYC—peripheral nervous system neoplasm	6.52e-05	0.00245	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—NRAS—peripheral nervous system neoplasm	6.52e-05	0.00245	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—EED—peripheral nervous system neoplasm	6.32e-05	0.00238	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.17e-05	0.00232	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	5.95e-05	0.00224	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—peripheral nervous system neoplasm	5.8e-05	0.00218	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	5.8e-05	0.00218	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	5.44e-05	0.00205	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—TP53—peripheral nervous system neoplasm	5.36e-05	0.00202	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—peripheral nervous system neoplasm	5.31e-05	0.002	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NTS—peripheral nervous system neoplasm	5.14e-05	0.00193	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.13e-05	0.00193	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—SUZ12—peripheral nervous system neoplasm	5.05e-05	0.0019	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—ENO2—peripheral nervous system neoplasm	5e-05	0.00188	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	4.93e-05	0.00186	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CD55—peripheral nervous system neoplasm	4.93e-05	0.00185	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—AKT1—peripheral nervous system neoplasm	4.92e-05	0.00185	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	4.82e-05	0.00181	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—HRAS—peripheral nervous system neoplasm	4.77e-05	0.00179	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—TP53—peripheral nervous system neoplasm	4.72e-05	0.00178	CbGpPWpGaD
Spironolactone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	4.66e-05	0.00175	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.65e-05	0.00175	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	4.65e-05	0.00175	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.49e-05	0.00169	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GNS—peripheral nervous system neoplasm	4.46e-05	0.00168	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	4.4e-05	0.00166	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	4.4e-05	0.00165	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ENO2—peripheral nervous system neoplasm	4.31e-05	0.00162	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—NME1—peripheral nervous system neoplasm	4.28e-05	0.00161	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.23e-05	0.00159	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—BCHE—peripheral nervous system neoplasm	4.22e-05	0.00159	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—AKT1—peripheral nervous system neoplasm	4.21e-05	0.00158	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	4.12e-05	0.00155	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—COX2—peripheral nervous system neoplasm	4.12e-05	0.00155	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	4.07e-05	0.00153	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.03e-05	0.00152	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—peripheral nervous system neoplasm	4.03e-05	0.00151	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	4.02e-05	0.00151	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—peripheral nervous system neoplasm	3.99e-05	0.0015	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—TH—peripheral nervous system neoplasm	3.97e-05	0.00149	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.91e-05	0.00147	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—VIP—peripheral nervous system neoplasm	3.9e-05	0.00147	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	3.85e-05	0.00145	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	3.82e-05	0.00144	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.76e-05	0.00142	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.74e-05	0.00141	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.67e-05	0.00138	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—BCHE—peripheral nervous system neoplasm	3.64e-05	0.00137	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	3.6e-05	0.00135	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.47e-05	0.00131	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—TH—peripheral nervous system neoplasm	3.42e-05	0.00129	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.41e-05	0.00128	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.34e-05	0.00126	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—GNAS—peripheral nervous system neoplasm	3.24e-05	0.00122	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	3.22e-05	0.00121	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—ABCB1—peripheral nervous system neoplasm	3.18e-05	0.0012	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	3.16e-05	0.00119	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.03e-05	0.00114	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GNAS—peripheral nervous system neoplasm	2.79e-05	0.00105	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.74e-05	0.00103	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ENO2—peripheral nervous system neoplasm	2.7e-05	0.00102	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.7e-05	0.00102	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	2.67e-05	0.00101	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.64e-05	0.000994	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	2.55e-05	0.000959	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.52e-05	0.000948	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	2.51e-05	0.000945	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.31e-05	0.000869	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—BCHE—peripheral nervous system neoplasm	2.28e-05	0.000859	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	2.22e-05	0.000834	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.2e-05	0.000828	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	2.19e-05	0.000825	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.18e-05	0.000819	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—TH—peripheral nervous system neoplasm	2.15e-05	0.000808	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	2.1e-05	0.000791	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	2.02e-05	0.000761	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.02e-05	0.00076	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	2.01e-05	0.000757	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.99e-05	0.000749	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—MYC—peripheral nervous system neoplasm	1.99e-05	0.000747	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	1.91e-05	0.00072	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.91e-05	0.000718	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.83e-05	0.000689	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.76e-05	0.000663	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.75e-05	0.000659	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.72e-05	0.000647	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.6e-05	0.000603	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.57e-05	0.000591	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	1.45e-05	0.000546	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.4e-05	0.000528	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—AKT1—peripheral nervous system neoplasm	1.38e-05	0.000518	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	1.33e-05	0.0005	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.29e-05	0.000485	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—MYC—peripheral nervous system neoplasm	1.21e-05	0.000455	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	1.16e-05	0.000435	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	1.12e-05	0.000422	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.11e-05	0.000417	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.09e-05	0.00041	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.07e-05	0.000403	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	1.05e-05	0.000397	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.01e-05	0.000379	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	9.77e-06	0.000368	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.32e-06	0.000351	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MYC—peripheral nervous system neoplasm	9.21e-06	0.000347	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	9.19e-06	0.000346	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—AKT1—peripheral nervous system neoplasm	8.75e-06	0.000329	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	8.61e-06	0.000324	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	8.45e-06	0.000318	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.44e-06	0.000318	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—AKT1—peripheral nervous system neoplasm	8.39e-06	0.000316	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.86e-06	0.000296	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—AKT1—peripheral nervous system neoplasm	7.54e-06	0.000284	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	7.5e-06	0.000282	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MYC—peripheral nervous system neoplasm	6.99e-06	0.000263	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.46e-06	0.000243	CbGpPWpGaD
Spironolactone—AR—Gene Expression—AKT1—peripheral nervous system neoplasm	6.39e-06	0.00024	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.17e-06	0.000232	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.45e-06	0.000205	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—AKT1—peripheral nervous system neoplasm	4.85e-06	0.000182	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—AKT1—peripheral nervous system neoplasm	4.73e-06	0.000178	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	2.32e-06	8.75e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	2.02e-06	7.62e-05	CbGpPWpGaD
